Neotrofin leteprinim (AIT-082): Discontinued Phase IIb/III trial

Based on results from its international Phase IIb trial and preliminary results from its U.S. Phase IIb trial, NEOT said Neotrofin is expected to have a greater benefit at higher doses, longer treatme...